Topiramate reduces neuronal injury after experimental status epilepticus

Brain Research

Volumn 837, Issue 1-2, 1999, Pages 263-269

  Niebauer, Marivi ^a   Gruenthal, Michael ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Hippocampus; Neuroprotection; Rat; Seizure; Status epilepticus; Topiramate

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; EPILEPTIC STATE; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; FRUCTOSE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NEURONS; RATS; RATS, WISTAR; STATUS EPILEPTICUS;

EID: 0033533162     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01615-7     Document Type: Article

References (24)

1. D.W. Choi, Glutamate neurotoxicity: a three-stage process, in: A. Guidotti (Ed.), Neurotoxicity of Excitatory Amino Acids, Vol. FIDIA Research Foundation Symposium Series Volume 4, Raven Press, New York, 1990, pp. 235-242.
2. DeGiorgio C.M., Tomiyasu U., Gott P.S., Treiman D.M. Hippocampal pyramidal cell loss in human status epilepticus. Epilepsia. 33:1992;23-27.
3. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 46:1996;1029-1035.
4. Edmonds H.L. Jr., Jiang Y.D., Zhang P.Y., Shank R.P. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sci. 59:1996;L127-131.
5. Goggins P., Gruenthal M. Effect of fosphenytoin on hippocampal neurotoxicity in a model of limbic status epilepticus. Epilepsia. 38:1997;226. Suppl. 8.
6. Gruenthal M. Electroencephalographic and histological characteristics of a model of limbic status epilepticus permitting direct control over seizure duration. Epilepsy Res. 29:1998;221-232.
7. Johannessen S.I. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia. 38:1997;S18-S23. Suppl. 1.
8. Jordan K.G. Status epilepticus. A perspective from the neuroscience intensive care unit. Neurosurgery Clinics of North America. 5:1994;671-686.
9. Lees G.J., Leong W. Synergy between diazepam and NBQX in preventing neuronal death caused by non-NMDA agonists. NeuroReport. 5:1994;2149-2152.
10. Leifer D., Cole D.G., Kowall N.W. Neuropathologic asymmetries in the brain of a patient with a unilateral status epilepticus. J. Neurol. Sci. 103:1991;127-135.
11. Lowenstein D.H., Alldredge B.K. Status epilepticus at an urban public hospital in the 1980s. Neurology. 43:1993;483-488.
12. Maglóczky Z., Freund T.F. Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield. Neuroscience. 66:1995;847-860.
13. Nadler J.V., Evenson D.A. Use of excitatory amino acids to make axon-sparing lesions in the hypothalamus. Methods in Enzymology. 103:1983;393-400.
14. Norman R.M. The neuropathology of status epilepticus. Med. Sci. Law. 4:1964;46-51.
15. Randall R.D., Thayer S.A. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. Journal of Neuroscience. 12:1992;1882-1895.
16. Severt L., Coulter D.A., Sombati S., DeLorenzo R.J. Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia. 36:1995;38. Suppl. 4.
17. Shank R.P., Gardocki J.F., Vaught J.L., Davis C.B., Schupsky J.J., Raffa R.B., Dodgson S.J., Nortey S.O., Maryanoff B.E. Topiramate: preclinical evaluation of structurally novel anticonvulsant. Epilepsia. 35:1994;450-460.
18. Sung C.-Y., Chu N.-S. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol. Scand. 80:1989;51-56.
19. Towne A.R., Pellock J.M., Ko D., DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia. 35:1994;27-34.
20. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., Handforth A., Faught E., Calabrese V.P., Uthman B.M., Ramsay R.E., Mamdani M.B. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N. Engl. J. Med. 339:1998;792-798.
21. Whetsell W.O. Jr. Current concepts of excitotoxicity. J. Neuropathol. Exp. Neurol. 55:1996;1-13.
22. White H.S., Brown D., Skeen G.A., Wolf H.H., Twyman R.E. The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked chloride currents. Epilepsia. 36:1995;1. Suppl. 3.
23. Yang Y., Shuaib A., Li Q., Siddiqui M.M. Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Res. 804:1998;169-176.
24. Zona C., Ciotti M.T., Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 231:1997;123-126.